 |
| Global Antihistamine Drugs Market |
The global antihistamine drugs market comprises various pharmaceutical products that provide relief from allergies by blocking histamine receptors. Antihistamine drugs are available in various forms including tablets, capsules, syrups, and topical creams. They work by inhibiting the effects of histamine, a chemical released during an allergic reaction. This prevents symptoms such as sneezing, itching, watery eyes, and runny nose associated with conditions like hay fever, hives, and eczema. The growing prevalence of allergic diseases and increasing awareness about their treatment have fueled the demand for antihistamine drugs globally.
The Global Antihistamine Drugs
Market is estimated to be valued at US$
78.89 BN in 2024 and is expected to exhibit a CAGR of 8.6% over the forecast period 2024 to 2031.
Key takeaways
Key players: Key players operating in the global antihistamine drugs market are
Bayer AG, Almirall S.A, GlaxoSmithKline, Johnson and Johnson, Sanofi, Pfizer
Inc., Sun Pharmaceutical Industries Limited, Merck & Co. Inc., Teva
Pharmaceutical Industries Ltd., Abbott Laboratories, Viatris Inc., Arlak
Biotech, Aden Healthcare, Sandoz Group AG, Hikma Pharmaceuticals PLC, Dr.
Reddy's Laboratories, and Cipla.
Growing demand:
The growing prevalence of allergic diseases and changing
lifestyles leading to increasing Global
Antihistamine Drugs Market Trends pollution levels have fueled the
demand for antihistamine drugs globally. According to statistics, more than 25%
of the global population suffers from allergies.
Global expansion: Leveraging the improving access to healthcare in emerging nations,
leading drug makers are expanding theirglobal footprints through partnerships
and licensing agreements. New product launches catering to unmet needs also
support the market growth.
Market key trends
One of the key trends emerging in the global antihistamine drugs market is the
increased demand for combination therapies. Leading manufacturers are focusing
on developing drugs that can provide relief from multiple allergy symptoms with
a single pill. Another notable trend is the rising popularity of novel delivery
systems. Topical patches and sublingual tablets that offer faster relief are
gaining traction. Furthermore, there is growing interest in developing
non-sedating antihistamines to overcome the side effect of drowsiness
associated with many traditional products. Sustained investments in R&D are
also expected to yield safer and more effective treatment options in the coming
years.
Porter’s Analysis
Threat of new entrants: New players find it difficult to enter the market due
to stringent regulations regarding clinical trials and manufacturing approvals.
Bargaining power of buyers: Buyers have moderate bargaining power due to the
availability of substitutes and existence of many branded and generic players.
Bargaining power of suppliers: Suppliers have low bargaining power due to the
availability of substitutes for raw materials.
Threat of new substitutes: Substitutes like corticosteroids, anti-leukotriene
medications pose low threat due to their specificity for specific conditions.
Competitive rivalry: The market is highly competitive with presence of many
global and local players.
Geographical Regions
North America accounts for the largest share of the global market in terms of
value due to high healthcare spending and robust penetration of prescription
drugs.
Asia Pacific is poised to be the fastest growing region due to rising
healthcare expenditure, increasing incidence of allergic diseases, expanding
patient pool, and presence of generic manufacturers.
Get
More Insights on, Global
Antihistamine Drugs Market
0 Comments